List view / Grid view

ZALTRAP (aflibercept)



Journal of Clinical Oncology publishes Phase III results of ZALTRAP® (aflibercept) VELOUR study

8 October 2012 | By

Sanofi (EURONEXT: SAN and NYSE: SNY) today announced that detailed results from the pivotal Phase III VELOUR study evaluating ZALTRAP® (aflibercept) Injection for Intravenous Infusion for the treatment of patients with previously treated metastatic colorectal cancer were published in the October 2012 edition of the Journal of Clinical Oncology (JCO).